Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer.
Primary and secondary therapeutic strategies for EGF receptor pathway inhibition in non-small-cell lung cancer. Expert Rev Anticancer Ther. 2010 Oct; 10(10):1589-99.